Pharmacovigilance Market Size to Grow USD 17.3 Billion 2030

Exclusive Report by Ameco Research: Pharmacovigilance Market Size Projected to Reach USD 17.3 Billion by 2030, Growing at 12.80% CAGR

According to Ameco Research's Pharmacovigilance Market report, The analysts took this into account when estimating the Pharmacovigilance Market size and CAGR for the respective industry. The report's author has thoroughly examined the market and concluded that the Pharmacovigilance Market's growth will level off in the coming years. In addition to that, the prominent qualitative information added in the report includes Pharmacovigilance Market trends, segmentation, key companies, SWOT, PORTER and PEST analysis, market maturity, value chain analysis, and others.

The global Pharmacovigilance Market research report is the well-analyzed solution for the decision-makers and academicians who are seeking a detailed analysis in terms of both qualitative as well as quantitative, for the historic period and for the upcoming years forecast. The research report encompasses the industry overview along with the forthcoming threats and supporting factors that will drive or hamper the market growth and provide opportunities in the near future.

Click here to get a Sample report copy@ https://www.amecoresearch.com/sample/207269

The Pharmacovigilance Market is finely segmented by considering the most important and responsive aspects of the respective market. Additionally, the segments are well analyzed for every geographical region including United States, European Union, China, Japan, India, Korea, and Southeast Asia. The major countries are covered with detailed information.

MARKET SEGMENTATION:

Market segment by Type, the product can be split into
Chemotherapy
Contract Outsourcing

Market segment by Application, split into
Pharma and Biotech Companies
Contract Research Organizations (CROs)
Business Process Outsourcing (BPO) Firms
Other Pharmacovigilance Service Providers

Apart from the segmentation, the market research report encompasses established strategic tools (Value Chain Analysis, Supply Channel Analysis, Porter's five forces model, and others) that help individuals in easy understanding and analyzing the overall information in a more comprehensive and systematic manner.

To receive personalized service, please share your research needs here@
https://www.amecoresearch.com/enquiry-before-buy/207269

KEY PLAYERS:

Eli Lilly and Company
ICON plc
Elsevier
Chiltern
Atlantic Research Group
Mapi Group
Clinquest Group B.V.
GSK
PRA Health Sciences, Inc.

Most of the top major players are being covered in the research report along with their product offerings, revenue contribution, regional presence, strategic developments, and business strength.

FEW SIGNIFICANT POINTS FROM TABLE OF CONTENT:
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Pharmacovigilance Market Size Growth Rate by Type (2013-2025)
1.4.2 Chemotherapy
1.4.3 Contract Outsourcing
1.5 Market by Application
1.5.1 Global Pharmacovigilance Market Share by Application (2013-2025)
1.5.2 Pharma and Biotech Companies
1.5.3 Contract Research Organizations (CROs)
1.5.4 Business Process Outsourcing (BPO) Firms
1.5.5 Other Pharmacovigilance Service Providers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Pharmacovigilance Market Size
2.2 Pharmacovigilance Growth Trends by Regions
2.2.1 Pharmacovigilance Market Size by Regions (2013-2025)
2.2.2 Pharmacovigilance Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Pharmacovigilance Market Size by Manufacturers
3.1.1 Global Pharmacovigilance Revenue by Manufacturers (2013-2018)
3.1.2 Global Pharmacovigilance Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Pharmacovigilance Market Concentration Ratio (CR5 and HHI)
3.2 Pharmacovigilance Key Players Head office and Area Served
3.3 Key Players Pharmacovigilance Product/Solution/Service
3.4 Date of Enter into Pharmacovigilance Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Pharmacovigilance Market Size by Type (2013-2018)
4.2 Global Pharmacovigilance Market Size by Application (2013-2018)

5 United States
5.1 United States Pharmacovigilance Market Size (2013-2018)
5.2 Pharmacovigilance Key Players in United States
5.3 United States Pharmacovigilance Market Size by Type
5.4 United States Pharmacovigilance Market Size by Application

6 Europe
6.1 Europe Pharmacovigilance Market Size (2013-2018)
6.2 Pharmacovigilance Key Players in Europe
6.3 Europe Pharmacovigilance Market Size by Type
6.4 Europe Pharmacovigilance Market Size by Application

7 China
7.1 China Pharmacovigilance Market Size (2013-2018)
7.2 Pharmacovigilance Key Players in China
7.3 China Pharmacovigilance Market Size by Type
7.4 China Pharmacovigilance Market Size by Application

8 Japan
8.1 Japan Pharmacovigilance Market Size (2013-2018)
8.2 Pharmacovigilance Key Players in Japan
8.3 Japan Pharmacovigilance Market Size by Type
8.4 Japan Pharmacovigilance Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Pharmacovigilance Market Size (2013-2018)
9.2 Pharmacovigilance Key Players in Southeast Asia
9.3 Southeast Asia Pharmacovigilance Market Size by Type
9.4 Southeast Asia Pharmacovigilance Market Size by Application

10 India
10.1 India Pharmacovigilance Market Size (2013-2018)
10.2 Pharmacovigilance Key Players in India
10.3 India Pharmacovigilance Market Size by Type
10.4 India Pharmacovigilance Market Size by Application

11 Central & South America
11.1 Central & South America Pharmacovigilance Market Size (2013-2018)
11.2 Pharmacovigilance Key Players in Central & South America
11.3 Central & South America Pharmacovigilance Market Size by Type
11.4 Central & South America Pharmacovigilance Market Size by Application

12 International Players Profiles
12.1 Eli Lilly and Company
12.1.1 Eli Lilly and Company Company Details
12.1.2 Company Description and Business Overview
12.1.3 Pharmacovigilance Introduction
12.1.4 Eli Lilly and Company Revenue in Pharmacovigilance Business (2013-2018)
12.1.5 Eli Lilly and Company Recent Development
12.2 ICON plc
12.2.1 ICON plc Company Details
12.2.2 Company Description and Business Overview
12.2.3 Pharmacovigilance Introduction
12.2.4 ICON plc Revenue in Pharmacovigilance Business (2013-2018)
12.2.5 ICON plc Recent Development
12.3 Elsevier
12.3.1 Elsevier Company Details
12.3.2 Company Description and Business Overview
12.3.3 Pharmacovigilance Introduction
12.3.4 Elsevier Revenue in Pharmacovigilance Business (2013-2018)
12.3.5 Elsevier Recent Development
12.4 Chiltern
12.4.1 Chiltern Company Details
12.4.2 Company Description and Business Overview
12.4.3 Pharmacovigilance Introduction
12.4.4 Chiltern Revenue in Pharmacovigilance Business (2013-2018)
12.4.5 Chiltern Recent Development
12.5 Atlantic Research Group
12.5.1 Atlantic Research Group Company Details
12.5.2 Company Description and Business Overview
12.5.3 Pharmacovigilance Introduction
12.5.4 Atlantic Research Group Revenue in Pharmacovigilance Business (2013-2018)
12.5.5 Atlantic Research Group Recent Development
12.6 Mapi Group
12.6.1 Mapi Group Company Details
12.6.2 Company Description and Business Overview
12.6.3 Pharmacovigilance Introduction
12.6.4 Mapi Group Revenue in Pharmacovigilance Business (2013-2018)
12.6.5 Mapi Group Recent Development
12.7.1 Company Details
12.7.2 Company Description and Business Overview
12.7.3 Pharmacovigilance Introduction
12.7.4 Revenue in Pharmacovigilance Business (2013-2018)
12.7.5 Recent Development
12.8 Clinquest Group B.V.
12.8.1 Clinquest Group B.V. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Pharmacovigilance Introduction
12.8.4 Clinquest Group B.V. Revenue in Pharmacovigilance Business (2013-2018)
12.8.5 Clinquest Group B.V. Recent Development
12.9 GSK
12.9.1 GSK Company Details
12.9.2 Company Description and Business Overview
12.9.3 Pharmacovigilance Introduction
12.9.4 GSK Revenue in Pharmacovigilance Business (2013-2018)
12.9.5 GSK Recent Development
12.10 PRA Health Sciences, Inc.
12.10.1 PRA Health Sciences, Inc. Company Details
12.10.2 Company Description and Business Overview
12.10.3 Pharmacovigilance Introduction
12.10.4 PRA Health Sciences, Inc. Revenue in Pharmacovigilance Business (2013-2018)
12.10.5 PRA Health Sciences, Inc. Recent Development

13 Market Forecast 2018-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2018-2025)
13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

To Purchase this Premium Report@ https://www.amecoresearch.com/buy/207269

201, Vaidehi-Saaket, Baner - Pashan Link Rd, Pashan, Pune, Maharashtra 411021

The complete information about our alliance publishers and the business verticals they cater to helps us in appropriately responding to our client requirements and identifying the potential opportunities in the market and suggest the research that can best suit client's requirement. Our comprehensive list of research reports boasts a complete collection of database casing almost every market category and sub-category.

This release was published on openPR.